Would You Want to Know If You're at Risk for Alzheimer’s?

Would You Want to Know If You’ll Get Alzheimer’s?

Meryl Comer:  We’re in a world of genomics.  James Watson who co-discovered the double-helix structure of DNA had his genome mapped and was only the second to have done it.  The cost has come down considerably.  I think it was a million dollars to have it done when he had it done. But he told Big Think that the one and only thing he didn’t want to know was his risk for Alzheimer’s.  Now do you think he made the right choice?

Dr. Troncoso:  I think the team might have not found anything.  The question is do you want to know whether you are high risk for Alzheimer’s disease.  I think it is a very personal decision.  Some people may not want to do it.  Others who are very practical for planning reasons may want to do it, but with the understanding that unless it is in one of these families, the 3%, you know.  In the rest of the population there is not a single marker that can tell you for sure they will have Alzheimer’s disease, even the most important one APOE you can have APOE4 alleles and you can still escape the disease. So it may be important for some people.  They want to plan their life, yeah, why not? But if you don’t want to do it I won’t blame you.

Meryl Comer: In terms of full disclosure about whether or not you want to know if you can’t treat for a disease like Alzheimer’s: I had the test.  I wanted to know for life planning.  Did you want to know?  Do you know?

Dr. Guarente:  No, my feeling is I would like to know about risk for any disease that can be treated, but for a disease for which there is really no treatment I would rather not know.

Dr. Arancio:  I don’t know and I don’t think it is important, partially for the same reason that he has said.  And the second thing he has said, what if I find out before I have two copies of APOE4?  I also know that doesn’t mean that I have developed necessarily disease and what if I know that I am the good apple and not the [...] or the [...]?  It does not mean that I have not developed the disease.

Dr. Troncoso:  I haven’t had a full genetic screening, but I do know my APOE, just at serendipity we needed blood when we started doing it in the lab.  I gave a sample and that is what I know and it’s okay, but I don’t have you know.  I didn’t do it because I wanted to know whether I would get Alzheimer’s disease.  Even if I knew that I have the E4 allele, that doesn’t mean high risk, but there is no certainty. 

Meryl Comer: Dr. Gandy?

Dr. Gandy:  I don’t know.  I tend to plan for the worst anyway, so planning I think I'm going to cover anyway.  I think the issue is whether one is ready to deal with that information psychologically, and I've never felt that I really wanted to have that thing sort of hanging around.

Dr. Troncoso:  There is one more twist to this.  It has to do with your children, so the question is if for some reason you’re going to have a child and you may want to know whether you have a gene that will increase the risk in them.  That would be the other situation which I would think about it.

Recorded on October 29, 2010

Genetic testing is advancing rapidly, and we can now find out our risk factor for developing Alzheimer’s. But without a cure or treatment available, what’s the point?

Compelling speakers do these 4 things every single time

The ability to speak clearly, succinctly, and powerfully is easier than you think

Former U.S. President Barack Obama speaks during a Democratic Congressional Campaign Committee rally at the Anaheim Convention Center on September 8, 2018 in Anaheim, California. (Photo by Barbara Davidson/Getty Images)
Personal Growth

The ability to communicate effectively can make or break a person's assessment of your intelligence, competence, and authenticity.

Keep reading Show less

Antimicrobial resistance is a growing threat to good health and well-being

Antimicrobial resistance is growing worldwide, rendering many "work horse" medicines ineffective. Without intervention, drug-resistant pathogens could lead to millions of deaths by 2050. Thankfully, companies like Pfizer are taking action.

Image courtesy of Pfizer.
Sponsored
  • Antimicrobial-resistant pathogens are one of the largest threats to global health today.
  • As we get older, our immune systems age, increasing our risk of life threatening infections. Without reliable antibiotics, life expectancy could decline for the first time in modern history.
  • If antibiotics become ineffective, common infections could result in hospitalization or even death. Life-saving interventions like cancer treatments and organ transplantation would become more difficult, more often resulting in death. Routine procedures would become hard to perform.
  • Without intervention, resistant pathogens could result in 10 million annual deaths by 2050.
  • By taking a multi-faceted approach—inclusive of adherence to good stewardship, surveillance and responsible manufacturing practices, as well as an emphasis on prevention and treatment—companies like Pfizer are fighting to help curb the spread.
Keep reading Show less

Preserving truth: How to confront and correct fake news

Journalism got a big wake up call in 2016. Can we be optimistic about the future of media?

Videos
  • "[T]o have a democracy that thrives and actually that manages to stay alive at all, you need regular citizens being able to get good, solid information," says Craig Newmark.
  • The only constructive way to deal with fake news? Support trustworthy media. In 2018, Newmark was announced as a major donor of two new media organizations, The City, which will report on New York City-area stories which may have otherwise gone unreported, and The Markup, which will report on technology.
  • Greater transparency of fact-checking within media organizations could help confront and correct fake news. Organizations already exist to make media more trustworthy — are we using them? There's The Trust Project, International Fact-Checkers Network, and Tech & Check.
Keep reading Show less